Bone loss induced by Runx2 over-expression in mice is blunted by osteoblastic over-expression of TIMP-1

Journal of Cellular Physiology

Volumn 222, Issue 1, 2010, Pages 219-229

  Schiltz, Corinne ^a,b   Prouillet, Christophe ^a,b   Marty, Caroline ^a,b   Merciris, Didier ^a,b   Collet, Corinne ^a   De Vernejoul, Marie Christine ^a,b   Geoffroy, Valérie ^a,b  

^a HÔPITAL LARIBOISIÈRE   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX METALLOPROTEINASE; OSTEOCALCIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSCRIPTION FACTOR RUNX2;

ANIMAL CELL; ARTICLE; BONE DENSITY; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; GENOTYPE; IN VIVO STUDY; MALE; MOUSE; NEWBORN; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OSTEOPENIA; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; TRANSGENICS;

AGING; ANIMALS; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; BONE RESORPTION; CELL DIFFERENTIATION; CORE BINDING FACTOR ALPHA 1 SUBUNIT; FEMALE; GENE EXPRESSION REGULATION; MICE; MICE, TRANSGENIC; OSTEOBLASTS; OSTEOCLASTS; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

MUS; MUS MUSCULUS;

EID: 73949128553     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21941     Document Type: Article

References (37)

1. Atkins GJ, Kostakis P, Pan B, Farrugia A, Gronthos S, Evdokiou A, Harrison K, Findlay DM, Zannettino AC. 2003. RANKL expression is related to the differentiation state of human osteoblasts. J Bone Miner Res 18:1088-1098.
2. Delaissé JM, Engsig MT, Everts V, del Carmen Ovejero M, Ferreras M, Lund L, Vu TH, Werb Z, Winding B, Lochter A, Karsdal MA, Troen T, Kirkegaard T, Lenhard T, Heegaard AM, Neff L, Baron R, Foged NT. 2000. Proteinases in bone resorption: Obvious and less obvious roles. Clin Chim Acta 291:223-234.
3. Delaissé JM, Andersen TL, Engsig MT, Henriksen K, Troen T, Blavier L. 2003. Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities. Microsc Res Tech 61:504-513.
4. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. 1997. Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell 89:747-754.
5. Ducy P, Starbuck M, Priemel M, Shen J, Pinero G, Geoffroy V, Amling M, Karsenty G. 1999. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev 13:1025-1036.
6. Eckstein F, Weusten A, Schmidt C, Wehr U, Wanke R, Rambeck W, Wolf E, Mohan S. 2004. Longitudinal in vivo effects of growth hormone overexpression on bone in transgenic mice. J Bone Miner Res 19:802-810.
7. Enomoto H, Shiojiri S, Hoshi K, Furuichi T, Fukuyama R, Yoshida CA, Kanatani N, Nakamura R, Mizuno A, Zanma A, Yano K, Yasuda H, Higashio K, Takada K, Komori T. 2003. Induction of osteoclast differentiation by Runx2 through receptor activator of nuclear factor-kappa B ligand (RANKL) and osteoprotegerin regulation and partial rescue of osteoclastogenesis in Runx2-/- mice by RANKL transgene. J Biol Chem 278:23971-23977.
8. Galindo M, Pratap J, Young DW, Hovhannisyan H, Im HJ, Choi JY, Lian JB, Stein JL, Stein GS, van Wijnen AJ. 2005. The bone-specific expression of Runx2 oscillates during the cell cycle to support a G1-related antiproliferative function in osteoblasts. J Biol Chem 280:20274-20285.
9. Geoffroy V, Kneissel M, Fournier B, Boyde A, Matthias P. 2002. High bone resorption in adult aging transgenic mice overexpressing cbfa1/runx2 in cells of the osteoblastic lineage. Mol Cell Biol 22:6222-6233.
10. Geoffroy V, Marty-Morieux C, Le Goupil N, Clement-Lacroix P, Terraz C, Frain M, Roux S, Rossert J, de Vernejoul MC. 2004. In vivo inhibition of osteoblastic metalloproteinases leads to increased trabecular bone mass. J Bone Miner Res 19:811-822.
11. Govoni KE, Lee SK, Chung YS, Behringer RR, Wergedal JE, Baylink DJ, Mohan S. 2007. Disruption of insulin-like growth factor-I expression in type IIalphaI collagen-expressing cells reduces bone length and width in mice. Physiol Genomics 30:354-362.
12. Guo LJ, Luo XH, Xie H, Zhou HD, Yuan LQ, Wang M, Liao EY. 2006. Tissue inhibitor of matrix metalloproteinase-1 suppresses apoptosis of mouse bone marrow stromal cell line MBA-1. Calcif Tissue Int 78:285-292.
13. Hess J, Porte D, Munz C, Angel P. 2001. AP-1 and Cbfa/runt physically interact and regulate parathyroid hormone-dependent MMP13 expression in osteoblasts through a new osteoblast-specific element 2/AP-1 composite element. J Biol Chem 276:20029-20038.
14. Holliday LS, Welgus HG, Fliszar CJ, Veith GM, Jeffrey JJ, Gluck SL. 1997. Initiation of osteoclast bone resorption by interstitial collagenase. J Biol Chem 272:22053-22058.
15. Jilka RL. 2007. Molecular and cellular mechanisms of the anabolic effect of intermittent PTH. Bone 40:1434-1446.
16. Jiménez MJ, Balbín M, López JM, Alvarez J, Komori T, López-Otín C. 1999. Collagenase 3 is a target of Cbfa1, a transcription factor of the runt gene family involved in bone formation. Mol Cell Biol 19:4431-4442.
17. Komori T. 2006. Regulation of osteoblast differentiation by transcription factors. J Cell Biochem 99:1233-1239.
18. Komori T. 2008. Regulation of bone development and maintenance by Runx2. Front Biosci 13:898-903.
19. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T. 1997. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755-764.
20. Lian JB, Stein GS, Javed A, van Wijnen AJ, Stein JL, Montecino M, Hassan MQ, Gaur T, Lengner CJ, Young DW. 2006. Networks and hubs for the transcriptional control of osteoblastogenesis. Rev Endocr Metab Disord 7:1-16.
21. Liu X, Wu H, Byrne M, Jeffrey J, Krane S, Jaenisch RA. 1995. Targeted mutation at the known collagenase cleavage site in mouse type I collagen impairs tissue remodeling. J Cell Biol 130:227-237.
22. Liu W, Toyosawa S, Furuichi T, Kanatani N, Yoshida C, Liu Y, Himeno M, Narai S, Yamaguchi A, Komori T. 2001. Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures. J Cell Biol 155:157-166.
23. Lochmüller EM, Jung V, Weusten A, Wehr U, Wolf E, Eckstein F. 2001. Precision of high-resolution dual energy X-ray absorptiometry of bone mineral status and body composition in small animal models. Eur Cell Mater 1:43-51.
24. Mannello F, Tonti GA, Bagnara GP, Papa S. 2006. Role and function of matrix metalloproteinases in the differentiation and biological characterization of mesenchymal stem cells. Stem Cells 24:475-481.
25. Merciris D, Schiltz C, Legoupil N, Marty-Morieux C, de Vernejoul MC, Geoffroy V. 2007a. Over-expression of TIMP-1 in osteoblasts increases the anabolic response to PTH. Bone 40:75-83.
26. Merciris D, Marty C, Collet C, de Vernejoul MC, Geoffroy V. 2007b. Overexpression of the transcriptional factor Runx2 in osteoblasts abolishes the anabolic effect of parathyroid hormone in vivo. Am J Pathol 170:1676-1685.
27. Mori K, Kitazawa R, Kondo T, Maeda S, Yamaguchi A, Kitazawa S. 2006. Modulation of mouse RANKL gene expression by Runx2 and PKA pathway. J Cell Biochem 98:1629-1644.
28. Notoya M, Otsuka E, Yamaguchi A, Hagiwara H. 2004. Runx-2 is not essential for the vitamin D-regulated expression of RANKL and osteoprotegerin in osteoblastic cells. Biochem Biophys Res Commun 324:655-660.
29. Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GW, Beddington RS, Mundlos S, Olsen BR, Selby PB, Owen MJ. 1997. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89:765-771.
30. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR. 1987. Bone histomorphometry: Standardization of nomenclature, symbols, and units. J Bone Miner Res 2:595-610.
31. Schiltz C, Marty C, de Vernejoul MC, Geoffroy V. 2008. Inhibition of the osteoblastic metalloproteinases prevents the bone loss induced by oestrogen deficiency. J Cell Biochem 104:1803-1817.
32. Schroeder TM, Jensen ED, Westendorf JJ. 2005. Runx2: A master organizer of gene transcription in developing and maturing osteoblasts. Birth Defects Res C Embryo Today 75:213-225.
33. Selvamurugan N, Pulumati MR, Tyson DR, Partridge NC. 2000. Parathyroid hormone regulation of the rat collagenase-3 promoter by protein kinase A-dependent transactivation of core binding factor alpha1. J Biol Chem 275:5037-5042.
34. Thirunavukkarasu K, Halladay DL, Miles RR, Yang X, Galvin RJ, Chandrasekhar S, Martin TJ, Onyia JE. 2000. The osteoblast-specific transcription factor Cbfa1 contributes to the expression of osteoprotegerin, a potent inhibitor of osteoclast differentiation and function. J Biol Chem 275:25163-25172.
35. Thomas GP, Baker SU, Eisman JA, Gardiner EM. 2001. Changing RANKL/OPG mRNA expression in differentiating murine primary osteoblasts. J Endocrinol 170:451-460.
36. Varghese S. 2006. Matrix metalloproteinases and their inhibitors in bone: An overview of regulation and functions. Front Biosci 11:2949-2966.
37. Witty JP, Foster SA, Stricklin GP, Matrisian LM, Stern PH. 1996. Parathyroid hormone-induced resorption in fetal rat limb bones is associated with production of the metalloproteinases collagenase and gelatinase B. J Bone Miner Res 11:72-78.